258 related articles for article (PubMed ID: 15201644)
61. Impact of blinded retrospective continuous glucose monitoring on clinical decision making and glycemic control in persons with type 2 diabetes on insulin therapy.
Ribeiro RT; Andrade R; Nascimento do Ó D; Lopes AF; Raposo JF
Nutr Metab Cardiovasc Dis; 2021 Apr; 31(4):1267-1275. PubMed ID: 33612381
[TBL] [Abstract][Full Text] [Related]
62. A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment.
Nauck MA; Haastert B; Trautner C; Müller UA; Nauck MA; Heinemann L;
Diabetologia; 2014 May; 57(5):868-77. PubMed ID: 24445534
[TBL] [Abstract][Full Text] [Related]
63. Effect of miglitol as an add-on to bolus insulin on postprandial glycemic excursions in type 2 diabetes patients assessed by continuous glucose monitoring.
Matsuura K; Mori Y; Nakamura A; Yokoyama J; Utsunomiya K
Diabetes Technol Ther; 2012 May; 14(5):423-9. PubMed ID: 22316114
[TBL] [Abstract][Full Text] [Related]
64. Baseline Glycated Hemoglobin Values Predict the Magnitude of Glycemic Improvement in Patients with Type 1 and Type 2 Diabetes: Subgroup Analyses from the DIAMOND Study Program.
Billings LK; Parkin CG; Price D
Diabetes Technol Ther; 2018 Aug; 20(8):561-565. PubMed ID: 30044123
[TBL] [Abstract][Full Text] [Related]
65. Efficacy of self-monitoring of blood glucose versus retrospective continuous glucose monitoring in improving glycaemic control in diabetic kidney disease patients.
Yeoh E; Lim BK; Fun S; Tong J; Yeoh LY; Sum CF; Subramaniam T; Lim SC
Nephrology (Carlton); 2018 Mar; 23(3):264-268. PubMed ID: 27933715
[TBL] [Abstract][Full Text] [Related]
66. Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial.
Dahl D; Onishi Y; Norwood P; Huh R; Bray R; Patel H; Rodríguez Á
JAMA; 2022 Feb; 327(6):534-545. PubMed ID: 35133415
[TBL] [Abstract][Full Text] [Related]
67. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry.
Karter AJ; Ackerson LM; Darbinian JA; D'Agostino RB; Ferrara A; Liu J; Selby JV
Am J Med; 2001 Jul; 111(1):1-9. PubMed ID: 11448654
[TBL] [Abstract][Full Text] [Related]
68. Insulin degludec/insulin aspart once daily in Type 2 diabetes: a comparison of simple or stepwise titration algorithms (BOOST
Park SW; Bebakar WM; Hernandez PG; Macura S; Hersløv ML; de la Rosa R
Diabet Med; 2017 Feb; 34(2):174-179. PubMed ID: 26773557
[TBL] [Abstract][Full Text] [Related]
69. U.K. prospective diabetes study. II. Reduction in HbA1c with basal insulin supplement, sulfonylurea, or biguanide therapy in maturity-onset diabetes. A multicenter study.
Diabetes; 1985 Aug; 34(8):793-8. PubMed ID: 2862087
[TBL] [Abstract][Full Text] [Related]
70. Changes in HbA1c level over a 12-week follow-up in patients with type 2 diabetes following a medication change.
Hirst JA; Stevens RJ; Farmer AJ
PLoS One; 2014; 9(3):e92458. PubMed ID: 24667212
[TBL] [Abstract][Full Text] [Related]
71. Glycemic control in patients with type 2 diabetes mellitus switched from twice-daily immediate-release metformin to a once-daily extended-release formulation.
Fujioka K; Pans M; Joyal S
Clin Ther; 2003 Feb; 25(2):515-29. PubMed ID: 12749511
[TBL] [Abstract][Full Text] [Related]
72. Reduction in hemoglobin A1C with real-time continuous glucose monitoring: results from a 12-week observational study.
Bailey TS; Zisser HC; Garg SK
Diabetes Technol Ther; 2007 Jun; 9(3):203-10. PubMed ID: 17561790
[TBL] [Abstract][Full Text] [Related]
73. Association of Potentially Modifiable Diabetes Care Factors With Glycemic Control in Patients With Insulin-Treated Type 2 Diabetes.
Lauffenburger JC; Lewey J; Jan S; Lee J; Ghazinouri R; Choudhry NK
JAMA Netw Open; 2020 Jan; 3(1):e1919645. PubMed ID: 31968115
[TBL] [Abstract][Full Text] [Related]
74. Self-Monitoring of Blood Glucose in Youth-Onset Type 2 Diabetes: Results From the TODAY Study.
Weinstock RS; Braffett BH; McGuigan P; Larkin ME; Grover NB; Walders-Abramson N; Laffel LM; Chan CL; Chang N; Schwartzman BE; Barajas RA; Celona-Jacobs N; Haymond MW;
Diabetes Care; 2019 May; 42(5):903-909. PubMed ID: 30833375
[TBL] [Abstract][Full Text] [Related]
75. Postprandial glucose monitoring further improved glycemia, lipids, and weight in persons with type 2 diabetes mellitus who had already reached hemoglobin A1c goal.
Zhang DA; Katznelson L; Li M
J Diabetes Sci Technol; 2012 Mar; 6(2):289-93. PubMed ID: 22538137
[TBL] [Abstract][Full Text] [Related]
76. The effect of real-time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial.
Secher AL; Ringholm L; Andersen HU; Damm P; Mathiesen ER
Diabetes Care; 2013 Jul; 36(7):1877-83. PubMed ID: 23349548
[TBL] [Abstract][Full Text] [Related]
77. Insulin pump therapy in patients with type 2 diabetes safely improved glycemic control using a simple insulin dosing regimen.
Edelman SV; Bode BW; Bailey TS; Kipnes MS; Brunelle R; Chen X; Frias JP
Diabetes Technol Ther; 2010 Aug; 12(8):627-33. PubMed ID: 20615104
[TBL] [Abstract][Full Text] [Related]
78. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi-center, multi-national, randomized controlled trial - Study protocol.
Feig DS; Asztalos E; Corcoy R; De Leiva A; Donovan L; Hod M; Jovanovic L; Keely E; Kollman C; McManus R; Murphy K; Ruedy K; Sanchez JJ; Tomlinson G; Murphy HR;
BMC Pregnancy Childbirth; 2016 Jul; 16(1):167. PubMed ID: 27430714
[TBL] [Abstract][Full Text] [Related]
79. HbA1c levels are better predicted by prebreakfast than postbreakfast blood glucose self-analyses in type 2 diabetes. Influence of duration of diabetes and mode of treatment.
Relimpio F; Guerrero R; Martínez-Brocca MA
Acta Diabetol; 2007 Jun; 44(2):55-9. PubMed ID: 17530467
[TBL] [Abstract][Full Text] [Related]
80. Comparison of continuous blood glucose measurement with conventional documentation of hypoglycemia in patients with Type 2 diabetes on multiple daily insulin injection therapy.
Zick R; Petersen B; Richter M; Haug C;
Diabetes Technol Ther; 2007 Dec; 9(6):483-92. PubMed ID: 18034602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
